Literature DB >> 11351154

Clinicopathologic profiles and prognosis of gastric carcinomas from the cardia, fundus/body and antrum.

J Pinto-De-Sousa1, L David, M Seixas, A Pimenta.   

Abstract

BACKGROUND/AIMS: The putative influence of tumor location on the biologic behavior of gastric carcinomas remains controversial. The aim of this study was to investigate if carcinomas arising in the three types of gastric mucosa (cardia, fundus/body and antrum) have different clinical and pathologic profiles and carry a different prognosis.
METHODS: Three hundred and two patients with cardia or gastric carcinoma resected between 1984 and 1996 were retrospectively studied. Cases were divided in three groups according to tumor location: cardia (n = 80); fundus/body (n = 60); antrum (n = 162). The three groups were crosstabulated with clinic and pathologic parameters, such as age, sex, macroscopy, histology, desmoplasia, tumor size, depth of tumor wall penetration, nodal status, venous invasion and stage. Survival rates were calculated for the three locations according to the aforementioned parameters. Univariate survival analysis and Cox regression were performed for each location.
RESULTS: Cases from the cardia and fundus/body were similar and distinct from antrum cases according to macroscopy, tumor size, depth of wall penetration, venous invasion, nodal status and stage. Cases from fundus/body were similar to antrum cases and distinct from cardia cases according to gender and Laurén's classification. An overall difference in survival between the three locations was observed (p = 0.006). Cumulative survival was better for patients with carcinomas in the antrum than in the cardia (p = 0.04) and in the fundus/body (p = 0.003); no significant differences were observed in survival between cardia and fundus/body carcinoma cases. Cox regression identified stage and venous invasion as prognostic factors for patients with carcinomas in the three locations. In the group of cardia tumors, older patients had a worse outcome and in the group of fundus/body carcinomas, large tumors were associated with a poorer survival.
CONCLUSIONS: Our results show that cardia carcinoma and antrum carcinoma are distinct gastric carcinoma entities whereas fundus/body carcinoma shares some characteristics from both entities. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11351154     DOI: 10.1159/000050109

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  20 in total

1.  Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 2.  Adjuvant and neoadjuvant therapy of gastric cancer: a comparison of three pivotal studies.

Authors:  Takeshi Sano
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

Review 3.  Gastric adenocarcinoma: review and considerations for future directions.

Authors:  Bryan J Dicken; David L Bigam; Carol Cass; John R Mackey; Anil A Joy; Stewart M Hamilton
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

4.  Clinical outcomes of upper gastrointestinal bleeding in patients with gastric gastrointestinal stromal tumor.

Authors:  Gyu Young Pih; Sung Jin Jeon; Ji Yong Ahn; Hee Kyong Na; Jeong Hoon Lee; Kee Wook Jung; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung; Seon-Ok Kim
Journal:  Surg Endosc       Date:  2019-05-06       Impact factor: 4.584

5.  Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.

Authors:  Liang-Hui Shi; Xiao-Qun Zhu; Guo-Hai Zhao; Ya-Bin Xia; Yi-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

6.  Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection.

Authors:  Joong-Min Park; Woo-Sang Ryu; Jong-Han Kim; Sung-Soo Park; Seung-Joo Kim; Chong-Suk Kim; Young-Jae Mok
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

7.  Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.

Authors:  Joana Gomes; Nuno T Marcos; Nora Berois; Eduardo Osinaga; Ana Magalhães; João Pinto-de-Sousa; Raquel Almeida; Fátima Gärtner; Celso A Reis
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

8.  Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.

Authors:  Yesim Gürbüz; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

9.  MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.

Authors:  J Pinto-de-Sousa; C A Reis; L David; A Pimenta; M Cardoso-de-Oliveira
Journal:  Virchows Arch       Date:  2004-01-31       Impact factor: 4.064

10.  Clinicopathologic characteristics and outcomes of surgery of middle-third gastric cancer.

Authors:  Jingyu Deng; Han Liang; Rupeng Zhang; Dan Sun; Yi Pan; Li Zhang; Xishan Hao
Journal:  Tumour Biol       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.